中药祛痰救肺汤联合针灸治疗预防COPD稳定期患者急性复发的价值  

Value of Qutanjiufeitang decoction combined with acupuncture in the treatment of patients with chronic obstructive pulmonary disease in stable stage

作　　者：冯超[1] 

机构地区：[1]海南省中医院呼吸科,海南海口570203

出　　处：《海南医学》2018年第2期177-180,共4页Hainan Medical Journal

基　　金：海南省卫生和计划生育委员会科研基金项目(编号:琼卫2011-85)

摘　　要：目的探讨中药祛痰救肺汤联合针灸治疗预防慢性阻塞性肺疾病(COPD)稳定期患者急性复发的临床效果。方法选取2014年6月至2015年6月海南省中医院收治的COPD稳定期患者120例,按随机数表法分为对照组和观察组各60例。对照组患者给予西医常规的祛痰、平喘治疗,而观察组则在对照组患者治疗的基础上给予中药祛痰救肺汤联合针灸治疗。于治疗前和治疗3个月后分别比较两组患者中医症状积分,并评估两组患者的临床疗效。比较两组患者治疗前后肺功能变化情况、步行6 min距离和生活质量。随访1年,观察并记录患者急性加重的次数。结果观察组患者的治疗总有效率为91.67%,明显高于对照组的78.33%,差异有统计学意义(P<0.05);观察组患者治疗后的步行6 min距离为(425.34±84.53)m,明显高于对照组的(375.46±96.12)m,差异有统计学意义(P<0.05);观察组患者治疗后的SGRQ评分和中医症状积分分别为(27.46±8.13)分和(7.06±2.12)分,均明显低于对照组的(36.08±10.93)分和(9.98±2.23)分,差异均有统计学意义(P<0.05);观察组患者治疗后的FVC、FEV1和PEF分别为(2.73±0.42)L、(2.64±0.53)L和(4.38±0.81)L/s,均明显高于对照组的(2.12±0.38)L、(1.85±0.55)L和(3.76±0.58)L/s,差异均有统计学意义(P<0.05);观察组患者急性加重的次数为(0.62±0.13)次,明显低于对照组的(1.72±0.45)次,差异有统计学意义(P<0.05)。结论稳定期COPD患者应用中药祛痰救肺汤联合针灸治疗,能有效改善临床症状和肺功能,同时降低急性复发的次数,提高患者的生活质量。Objective To discuss the application value of Qutanjiufeitang decoction and acupuncture in the treatment of patients with chronic obstructive pulmonary disease（COPD） of stable stage. Methods A total of 120 patients with COPD of stable stage in our hospital from June 2014 to June 2015 were selected and divided into two groups（60 patients in each group）. Patients in the control group received conventional treatments, while the patients in the observation group applied Qutanjiufeitang decoction combined with acupuncture based on conventional treatments.The traditional Chinese medicine（TCM） syndrome integral before treatment and 3 months after treatment were evaluated, and the clinical effects were compared between the two groups. Lung function, 6-min walk test, and quality of life were also compared. The patients were followed up for 1 year, and the times of acute relapse were observed and recorded. Results The total effective rate in observation group was 91.67%, which was significantly higher than 78.33%in control group（P0.05）. The 6-min walk distance was（425.34 ± 84.53） m after treatment in the observation group,which was significantly higher than（375.46±96.12） m in the control group（P0.05）. The SGRQ scores and TCM syndrome integral were（27.46±8.13） and（7.06±2.12） after treatment in the observation group, which were significantly lower than（36.08±10.93） and（9.98±2.23） in the control group（P0.05）. The forced vital capacity（FVC）, forced expiratory volume in one second（FEV1） and peak expiratory flow（PEF） were（2.73±0.42） L,（2.64±0.53） L and（4.38±0.81） L/s after treatment in the observation group, which were significantly higher than（2.12±0.38） L,（1.85±0.55） L,（3.76±0.58） L/s in the control group（P0.05）. The times of acute relapse was（0.62±0.13） during the follow-up in the observation group,which was lower than（1.72 ± 0.45） in the control group（P0.05）. Conclusion Qutanjiufeitang decoction combined with acu

关 键 词：祛痰救肺汤 针灸 慢性阻塞性肺疾病 稳定期 临床疗效 

分 类 号：R563[医药卫生—呼吸系统]